Clinical Drug Experience Knowledgebase

autologous hematopoietic stem cells (2 trials)

cd19 car-t cells (3 trials)

psma car-t cell (1 trial)

1a46 (1 trial)

br101 (1 trial)

br108 (1 trial)

brl-101 (1 trial)

bry812 (1 trial)

cd19-targeted non-viral pd1 site-specific integrated car-t cell injection (1 trial)

measles, mumps, and rubella vaccine (MMR) (1 trial)

pd1-psma-cart cells (1 trial)

secukinumab (cosentyx) (1 trial)

bcma-pd1-cart cell (1 trial)

brl-301 (2 trials)

cd19-specific chimeric antigen receptor t cells with pd1 knockout (1 trial)

ciltacabtagene autoleucel (Carvykti) (1 trial)

cyclophosphamide (cytoxan) (1 trial)

fludarabine (fludara) (1 trial)

pd1-bcma-cart (1 trial)

β-globin restored autologous hsc (1 trial)